Format

Send to:

Choose Destination
See comment in PubMed Commons below
Urol Int. 2010;85(4):401-5. doi: 10.1159/000315991. Epub 2010 Jul 20.

p53 codon 72 increased biochemical recurrence risk after radical prostatectomy in a southern Chinese population.

Author information

  • 1Department of Urology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Abstract

INTRODUCTION:

Alterations in P53 and murine double minute 2 (MDM2) genes appear to be important in the development of many human tumors. We investigated the potential prognostic roles of p53 codon 72 and MDM2 309 and 1797 polymorphisms in prostate cancer after radical prostatectomy.

PATIENTS AND METHODS:

Fifty southern Chinese with prostate cancer undergoing radical prostatectomy were included in this study. All polymorphisms were detected by PCR-RFLP. Their prognosis on biochemical recurrence was assessed using Kaplan-Meier analysis and Cox regression model.

RESULTS:

p53 codon 72 GG genotype was associated with increased biochemical recurrence compared with CG+CC genotypes and poorer PSA-free survival. It was also noted that GG genotype was an independent risk factor for biochemical recurrence after radical prostatectomy on multivariate analysis. No statistical difference was observed in MDM2 polymorphisms and prostate cancer prognosis.

CONCLUSION:

Our data revealed that p53 codon 72 GG genotype carriers more frequently show biochemical recurrence than CG+CC genotypes carriers.

Copyright © 2010 S. Karger AG, Basel.

PMID:
20664183
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland
    Loading ...
    Write to the Help Desk